Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Merzon

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
The American Journal of Medicine|April 3, 2026
Chronic Idiopathic Eosinopenia and Long-Term Cardiovascular Outcomes: A Population-Based Cohort StudyEli Magen, Eugene Merzon, Israel Magen, et al.
Digestive Diseases (Basel, Switzerland)|July 10, 2026
IgE-Mediated Food Allergy in Patients with Celiac DiseaseEli Magen, Eugene Merzon, Israel Magen, et al.
Microorganisms|June 24, 2022
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines ReceivedAriel Israel, Alejandro A Schäffer, Eugene Merzon, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
The FEBS Journal|February 23, 2021
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infectionEugene Merzon, Ilan Green, Shlomo Vinker, et al.
European Journal of Pediatrics|September 26, 2024
Low utility of serum folic acid blood tests in healthy children and adolescents, a nationwide cohortMichal Vinker-Shuster, Amber Nakar-Weinstein, Chani Topf-Olivestone, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Predicting COVID-19 severity using major risk factors and received vaccinesAriel Israel, Alejandro A Schäffer, Eugene Merzon, et al.
The American Journal of Medicine|January 11, 2026
Familial Mediterranean Fever and Long-Term Cardiovascular Disease BurdenEli Magen, Suhail Aamar, Eugene Merzon, et al.
Musculoskeletal Care|August 17, 2024
Drug Survival on First Biologic Therapy Among Late-Onset Rheumatoid Arthritis Patients Compared to Early-Onset Patients: A Population-Based Cohort StudyHelana Jeries, Rula Daood, Basem Hijazi, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
The American Journal of Medicine|April 3, 2026
Chronic Idiopathic Eosinopenia and Long-Term Cardiovascular Outcomes: A Population-Based Cohort StudyEli Magen, Eugene Merzon, Israel Magen, et al.
Digestive Diseases (Basel, Switzerland)|July 10, 2026
IgE-Mediated Food Allergy in Patients with Celiac DiseaseEli Magen, Eugene Merzon, Israel Magen, et al.
Microorganisms|June 24, 2022
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines ReceivedAriel Israel, Alejandro A Schäffer, Eugene Merzon, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
The FEBS Journal|February 23, 2021
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID-19 infectionEugene Merzon, Ilan Green, Shlomo Vinker, et al.
European Journal of Pediatrics|September 26, 2024
Low utility of serum folic acid blood tests in healthy children and adolescents, a nationwide cohortMichal Vinker-Shuster, Amber Nakar-Weinstein, Chani Topf-Olivestone, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Predicting COVID-19 severity using major risk factors and received vaccinesAriel Israel, Alejandro A Schäffer, Eugene Merzon, et al.
The American Journal of Medicine|January 11, 2026
Familial Mediterranean Fever and Long-Term Cardiovascular Disease BurdenEli Magen, Suhail Aamar, Eugene Merzon, et al.
Musculoskeletal Care|August 17, 2024
Drug Survival on First Biologic Therapy Among Late-Onset Rheumatoid Arthritis Patients Compared to Early-Onset Patients: A Population-Based Cohort StudyHelana Jeries, Rula Daood, Basem Hijazi, et al.
Pageof 12